Abstract PD2-01: Randomized phase 3 trial of adjuvant letrozole versus anastrozole in postmenopausal patients with hormone receptor positive, node positive early breast cancer: Final efficacy and safety results of the femara versus anastrozole clinical evaluation (Face) trial Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • O'Shaughnessy, J
  • Yardley, DA
  • Burris, HA
  • De Boer, R
  • Amadori, D
  • McIntyre, K
  • Ejlertsen, B
  • Gnant, M
  • Jonat, W
  • Pritchard, Kathleen
  • Dowsett, M
  • Hart, L
  • Poggio, S
  • Valagussa, P
  • Salomon, H
  • Wamil, B
  • Smith, I

publication date

  • February 15, 2016